Applications published 29 November 2006

Benzamide and benzoate anti-HIV compounds
Samaritan Pharmaceuticals; Georgetown University, Papadopoulos, Vassilos; Greeson, Janet 1725098*

Peptide mixtures with immunomodulatory activity
Mixture Sciences; The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1725099*

2-pyridinyl [7-(substituted-pyridin-4-yl) pyrazolo[1,5-A] pyrimidin-3-yl] methanones
DOV Pharmaceuticals 1725101*

HIV integrase inhibitors
Merck 1725102*

Methods and compsns for inhibition of metastasis
The Scripps Research Institute 1725111*

Processes for the preparation of solid dosage forms of amorphous valganciclovir hydrochloride
Ranbaxy Laboratories 1725217*

Pharmaceutical compsn comprising pimobendan
Boehringer Ingelheim Vetmedica 1725218*

Method and apparatus for automatically modifying delivery profile of drug delivery system
Medical Research Products 1725219*

Effervescent formulations comprising desmopressin
Ardana Bioscience 1725220*

Use of MRP4-inhibitors for the treatment and/or prophylaxis of cardiovascular diseases
Ernst-Moritz-Arndt-Universitaet 1725221*

Methods and compsns for treating or preventing psychiatric disorders with COX-2 inhibitors alone and in combination with anti-depressant agents
Pharmacia 1725222*

Use of antagonists of the CB1 receptor for the manufacture of a compsn useful for the treatment of hepatic diseases
INSERM; Sanofi-Aventis 1725223*

Methods and compsns comprising non-peptide small molecules that solubilise beta amyloid peptide fibre
AC Immune 1725224*

Ambroxol for treating acute pains
Boehringer Ingelheim International 1725225*

The treatment of inflammatory disorders and pain using beta-aminoalcohols
Sosei R&D 1725226*

Use of new lipoxygenase inhibitors
Biolipox 1725227*

Use of docosatrienes, resolvins and their stable analogues in the treatment of airway diseases and asthma
The Brigham and Women's Hospital 1725228*

Use of desoxypeganine for the treatment of schizophrenic psychoses
HF Arzneimittelforschung 1725229*

Methimazole derivatives and tautomeric cyclic thiones to inhibit cell adhesion
Intherthyr 1725230*

Trizole, oxadiazole and thiadiazole derivatives as PPAR modulators for the treatment of diabetes
Eli Lilly 1725231*

(Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
NV Organon 1725232*

SNS-595 and methods of using the same
Sunesis Pharmaceuticals 1725233*

Methods of treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimising side-effects
The Trustees of the University of Pennsylvania 1725234*

Piperidine derivatives useful as CCR3 antagonists
Schering 1725235*

Novel M3 muscarinic acetylcholine receptor antagonists
Glaxo 1725236*

Methods for treating alcoholism
Alkermes Controlled Therapeutics 1725237*

M3 muscarinic acetylcholine receptor antagonists
Glaxo 1725238*

4-(sulphanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
F Hoffmann-La Roche 1725239*

Muscarinic acetylcholine receptor antagonists
Glaxo 1725240*

M3 muscarinic acetylcholine receptor antagonists
Glaxo 1725241*

Boronate medicaments suitable for short duration anticoagulation
Trigen 1725242*

Boronate medicaments for preventing thrombosis during surgery
Trigen 1725243*

Method of preventing fibrin clots in pulmonary tissue through the use of aerosolised anticoagulants
GTC Biotherapeutics 1725244*

Manganese and iron based compounds for elastogenesis and connective tissue treatment
Human Matrix Sciences; University of Toronto 1725245*

Compsns containing internally activated antioxidant
E-L Management 1725246*

Polyphenols as an intravesical agent for the prevention of transitional cell tumour implantation
The Medical College of Ohio 1725247*

Preparations containing echinacea extracts and thiocyanate
Riemsar Arzneimittel 1725248*

Monomethylvaline compounds capable of conjugation to ligands
Seattle Genetics 1725249*

Method for the preparation of peptide-oligonucleotide conjugates
Frutarom; Yissum Research Development Company of the Hebrew University of Jerusalem 1725250*

Selective incorporation of 5-hydroxytrypophan into proteins in mammalian cells
The Scripps Research Institute 1725251*

Antitumour treatments with metxia-p450 and cyclophosphamide or 5T4 vaccine
Oxford Biomedica 1725252*

Medicaments and methods for treating headache
Allergan 1725253*

Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity
The Trustees of Columbia University in the City of New York 1725254*

Polypeptides for inducing a protective immune response against Staphylococcus aureus
Merck 1725255*

A vaccine formulated for administration to mucosa of the lungs
The University of Newcastle Research Associates 1725256*

Combination vaccines with low dose of HIB conjugate
Chiron 1725258*

Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof, therapeutic uses thereof
Institut Pasteur 1725259*

Vaccine for preventing and/or treating a herpes virus infection
RWTH Aachen 1725260*

Use for interleukin-33 (IL-33) and the IL-33 receptor complex
Schering 1725261*

Polymer-based compsns and conjugates of HIV entry inhibitors
Nektar Therapeutics 1725262*

Stable, palatable syrup containing ibuprofen and method of its preparation
I.Q.A 1752263*

Antibody calcheamicin conjugates for passive targeting
Wyeth 1725264*

Calicheamicin conjugates by antibody deglycosylation
Wyeth 1725265*

Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
Hybridon 1725266*

Enzyme-prodrug therapy for prosthetic joint repair
Innovata 1725267*